Hirayama disease: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Hirayama disease | |||
| image = [[File:Cervical_spine_125153_rgbca_67m.png|left|thumb|Cervical spine MRI showing features of Hirayama disease]] | |||
| caption = MRI of the cervical spine in a patient with Hirayama disease | |||
| synonyms = Monomelic amyotrophy, juvenile muscular atrophy of distal upper extremity | |||
| specialty = [[Neurology]] | |||
| symptoms = [[Muscle weakness]], [[muscle atrophy]] in the hand and forearm | |||
| onset = Adolescence or early adulthood | |||
| duration = Progressive over several years, then stabilizes | |||
| causes = [[Spinal cord]] compression due to forward displacement of the posterior dural sac | |||
| risks = Male gender, age 15-25 | |||
| diagnosis = [[Magnetic resonance imaging|MRI]], clinical examination | |||
| differential = [[Amyotrophic lateral sclerosis]], [[spinal muscular atrophy]], [[cervical spondylotic myelopathy]] | |||
| treatment = [[Physical therapy]], [[cervical collar]], surgical intervention in severe cases | |||
| prognosis = Generally good, with stabilization of symptoms | |||
| frequency = Rare, more common in [[Asia]] | |||
}} | |||
== Hirayama Disease == | == Hirayama Disease == | ||
[[File:Modern_3T_MRI.JPG|left|thumb|Modern 3T MRI machine used for diagnosing Hirayama disease]] | |||
[[File:Modern_3T_MRI.JPG|thumb | |||
'''Hirayama disease''', also known as monomelic amyotrophy, is a rare neurological disorder characterized by muscle weakness and atrophy in the distal upper limbs. It predominantly affects young males and is considered a type of motor neuron disease. | '''Hirayama disease''', also known as monomelic amyotrophy, is a rare neurological disorder characterized by muscle weakness and atrophy in the distal upper limbs. It predominantly affects young males and is considered a type of motor neuron disease. | ||
== Pathophysiology == | == Pathophysiology == | ||
Hirayama disease is believed to be caused by a dynamic compression of the cervical spinal cord during neck flexion. This compression leads to ischemia and subsequent damage to the anterior horn cells, which are responsible for innervating the muscles of the hand and forearm. | Hirayama disease is believed to be caused by a dynamic compression of the cervical spinal cord during neck flexion. This compression leads to ischemia and subsequent damage to the anterior horn cells, which are responsible for innervating the muscles of the hand and forearm. | ||
== Clinical Presentation == | == Clinical Presentation == | ||
Patients with Hirayama disease typically present with insidious onset of unilateral or asymmetric weakness and atrophy of the hand and forearm muscles. The condition is often painless and progresses slowly over several years before stabilizing. | Patients with Hirayama disease typically present with insidious onset of unilateral or asymmetric weakness and atrophy of the hand and forearm muscles. The condition is often painless and progresses slowly over several years before stabilizing. | ||
== Diagnosis == | == Diagnosis == | ||
The diagnosis of Hirayama disease is primarily clinical, supported by imaging studies. [[Magnetic resonance imaging|MRI]] of the cervical spine is crucial for diagnosis, as it can demonstrate the forward displacement of the posterior dural sac and the loss of attachment to the vertebral bodies during neck flexion. | The diagnosis of Hirayama disease is primarily clinical, supported by imaging studies. [[Magnetic resonance imaging|MRI]] of the cervical spine is crucial for diagnosis, as it can demonstrate the forward displacement of the posterior dural sac and the loss of attachment to the vertebral bodies during neck flexion. | ||
== Treatment == | == Treatment == | ||
There is no definitive cure for Hirayama disease. Management focuses on preventing further progression and alleviating symptoms. Patients are often advised to avoid neck flexion and may be fitted with a cervical collar. Physical therapy can help maintain muscle strength and function. | There is no definitive cure for Hirayama disease. Management focuses on preventing further progression and alleviating symptoms. Patients are often advised to avoid neck flexion and may be fitted with a cervical collar. Physical therapy can help maintain muscle strength and function. | ||
== Prognosis == | == Prognosis == | ||
The prognosis for Hirayama disease is generally favorable, with many patients experiencing stabilization of symptoms after a few years. However, some degree of muscle weakness and atrophy may persist. | The prognosis for Hirayama disease is generally favorable, with many patients experiencing stabilization of symptoms after a few years. However, some degree of muscle weakness and atrophy may persist. | ||
== See also == | |||
== | |||
* [[Motor neuron disease]] | * [[Motor neuron disease]] | ||
* [[Spinal cord]] | * [[Spinal cord]] | ||
* [[Muscle atrophy]] | * [[Muscle atrophy]] | ||
[[Category:Neurological disorders]] | [[Category:Neurological disorders]] | ||
Latest revision as of 04:04, 7 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Hirayama disease | |
|---|---|
 | |
| Synonyms | Monomelic amyotrophy, juvenile muscular atrophy of distal upper extremity |
| Pronounce | N/A |
| Specialty | Neurology |
| Symptoms | Muscle weakness, muscle atrophy in the hand and forearm |
| Complications | N/A |
| Onset | Adolescence or early adulthood |
| Duration | Progressive over several years, then stabilizes |
| Types | N/A |
| Causes | Spinal cord compression due to forward displacement of the posterior dural sac |
| Risks | Male gender, age 15-25 |
| Diagnosis | MRI, clinical examination |
| Differential diagnosis | Amyotrophic lateral sclerosis, spinal muscular atrophy, cervical spondylotic myelopathy |
| Prevention | N/A |
| Treatment | Physical therapy, cervical collar, surgical intervention in severe cases |
| Medication | N/A |
| Prognosis | Generally good, with stabilization of symptoms |
| Frequency | Rare, more common in Asia |
| Deaths | N/A |
Hirayama Disease[edit]
Hirayama disease, also known as monomelic amyotrophy, is a rare neurological disorder characterized by muscle weakness and atrophy in the distal upper limbs. It predominantly affects young males and is considered a type of motor neuron disease.
Pathophysiology[edit]
Hirayama disease is believed to be caused by a dynamic compression of the cervical spinal cord during neck flexion. This compression leads to ischemia and subsequent damage to the anterior horn cells, which are responsible for innervating the muscles of the hand and forearm.
Clinical Presentation[edit]
Patients with Hirayama disease typically present with insidious onset of unilateral or asymmetric weakness and atrophy of the hand and forearm muscles. The condition is often painless and progresses slowly over several years before stabilizing.
Diagnosis[edit]
The diagnosis of Hirayama disease is primarily clinical, supported by imaging studies. MRI of the cervical spine is crucial for diagnosis, as it can demonstrate the forward displacement of the posterior dural sac and the loss of attachment to the vertebral bodies during neck flexion.
Treatment[edit]
There is no definitive cure for Hirayama disease. Management focuses on preventing further progression and alleviating symptoms. Patients are often advised to avoid neck flexion and may be fitted with a cervical collar. Physical therapy can help maintain muscle strength and function.
Prognosis[edit]
The prognosis for Hirayama disease is generally favorable, with many patients experiencing stabilization of symptoms after a few years. However, some degree of muscle weakness and atrophy may persist.
